 NAPLES, Fla., May 18, 2021 PRNewswire -- Enveric Biosciences, Inc. NASDAQ: ENVB Enveric or the Company, a patient-first biotechnology company developing novel cannabinoid CBD medicines to improve quality of life for cancer patients, today reported its financial results for the three months ended March 31, 2021. 